Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2015 Jun 14;93(2):418–424. doi: 10.1016/j.ijrobp.2015.06.014

Table 1.

Patient, tumor, and treatment characteristics

Characteristic n %
Age (y), median (range) 77 (49–95)
KPS, median (range) 70 (50–100)
Gender
  Male 138 46.8
  Female 157 53.2
BMI (kg/m2)*
  <30 225 71.2
  ≥30 (obesity) 91 28.8
Tumor
  Primary NSCLC 285 90.2
  Oligometastatic 13 4.1
  Recurrent 18 5.7
Tumor distance to CW (cm)
  <1 218 69.0
  ≥1 98 31.0
Prescription doses
  18–20 Gy × 3 113 35.8
  12 Gy × 4 114 36.1
  9–10 Gy × 5 62 19.6
  Other 27 8.5

Abbreviations: BMI = body mass index; CW = chest wall; KPS = Karnofsky performance status; NSCLC = non-small cell lung cancer.

*

Body mass index for patients with multiple treatments was calculated separately before each treatment.